A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Summary

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD. The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.

Timeline

Start

2026-03-27

Primary completion

2028-06-30

Completion

2028-06-30

Drugs

Indications